Loading...
Loading...
Blade Air Mobility Inc BLDE reported first-quarter FY23 revenue growth of 70% year-over-year to $45.27 million, beating the consensus of $40.51 million.
- Passenger revenue grew 32.6% Y/Y to $18.5 million, and Medical revenue +111.2% Y/Y to $26.78 million.
- Flight profit rose to $7.16 million (+145.1% Y/Y), and the margin improved by 485 bps to 15.8%.
- Strong growth in BLDE's MediMobility Organ Transport business, Blade Canada, and contribution from Blade Europe acquisitions drove flight profit.
- Loss per share improved to $(0.14), from $(0.16) in 1Q22, beating the consensus of $(0.21).
- Loss from operations contracted to $(12.83) million, compared to $(13.69) million a year ago.
- Adjusted EBITDA loss was flat YoY at $(7.72) million, margin improved to (17.1%) from (29%) in 1Q22.
- Blade's net cash used in operating activities for the quarter totaled $(16.86) million, compared to $(10.07) million a year ago.
- The company held cash and cash equivalents of $41.74 million as of March 31, 2023.
- Blade continues to demonstrate the leverage of its air mobility platform as year-over-year Flight Profit growth significantly exceeded the growth rate in Revenue and Adjusted Corporate Expense, CFO Will Heyburn said.
- Price Action: BLDE shares are trading higher by 7.29% at $3.09 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in